Showing results (11-20 of 80) with videos related to
Sort By:
Pageof 8
Expert Review of Cardiovascular Therapy|May 28, 2011
The relative importance of common and rare genetic variants in the development of hypertriglyceridemiaDavid Evans, Jens Aberle, Frank-Ulrich BeilDeutsche Medizinische Wochenschrift (1946)|October 5, 2016
[Adipositas - new aspects in internistic care before and after bariatric surgery]Clarissa Schulze Zur Wiesch, Anne Lautenbach, Jens AberleDeutsche Medizinische Wochenschrift (1946)|July 26, 2023
["Treatment of obesity - State of the art"]Clarissa Schulze Zur Wiesch, Anne Lautenbach, Jens AberleInternational Journal of Medical Sciences|August 15, 2006
Association of the T+294C polymorphism in PPAR delta with low HDL cholesterol and coronary heart disease risk in womenJens Aberle, Inga Hopfer, Frank Ulrich Beil, et al.Plos One|May 4, 2021
Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetesAnna-Katharina Böhm, Udo Schneider, Jens Aberle, et al.Acta Neurochirurgica|February 22, 2021
4K 3-dimensional video microscope system (orbeye) for transsphenoidal pituitary surgeryRoman Rotermund, Jan Regelsberger, Katharina Osterhage, et al.Archives of Gynecology and Obstetrics|February 8, 2024
Obesity management: sex-specific considerationsTobias Kantowski, Clarissa Schulze Zur Wiesch, Jens Aberle, et al.Diabetes, Obesity & Metabolism|February 10, 2019
Weight loss in patients with type 2 diabetes receiving once-weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: A post-hoc analysis of the AWARD-4 study across baseline body mass index subgroupsMartin Fuechtenbusch, Jens Aberle, Elke Heitmann, et al.Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|March 21, 2018
Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegalyRoman Rotermund, Till Burkhardt, Zaina Rohani, et al.Diabetes, Obesity & Metabolism|December 14, 2022
Investigating the potential non-authorized use of two different formulations of liraglutide in Europe: A real-world drug utilization studyPaolo Sbraccia, Jens Aberle, Anne Helene Olsen, et al.Pageof 8